Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-05 06:08 am Sale | 2023-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Sumitomo Mitsui Trust Group Inc. | 1,320,652 4.940% | -128,408 (-8.86%) | Filing History |
| 2024-01-29 4:01 pm Purchase | 2023-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | ARK Investment Management LLC | 2,047,687 7.660% | 35,258 (+1.75%) | Filing History |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | BlackRock, Inc. BLK | 2,398,296 9.000% | 513,411 (+27.24%) | Filing History |
| 2024-01-25 07:48 am Sale | 2023-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | STATE STREET CORPORATION STT | 1,629,666 6.100% | -38,259 (-2.29%) | Filing History |
| 2024-01-17 2:43 pm Purchase | 2023-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Federated Hermes, Inc. FHI | 4,711,512 17.630% | 471,958 (+11.13%) | Filing History |
| 2023-10-10 11:20 am Sale | 2023-09-30 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | STATE STREET CORPORATION STT | 1,667,925 6.270% | -589,921 (-26.13%) | Filing History |
| 2023-02-10 10:48 am Sale | 2022-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | ARK Investment Management LLC | 2,012,429 7.580% | -460,201 (-18.61%) | Filing History |
| 2023-02-10 10:29 am Purchase | 2022-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Amova Asset Management Americas Inc. | 1,449,060 5.450% | 91,588 (+6.75%) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | VANGUARD GROUP INC | 1,450,425 5.460% | 1,450,425 (New Position) | Filing History |
| 2023-02-08 09:52 am Sale | 2022-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | STATE STREET CORPORATION STT | 2,257,846 8.500% | -960,111 (-29.84%) | Filing History |
| 2023-02-03 06:10 am Purchase | 2022-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Sumitomo Mitsui Trust Group Inc. | 1,449,060 5.450% | 91,588 (+6.75%) | Filing History |
| 2023-02-01 10:11 am Purchase | 2022-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Federated Hermes, Inc. FHI | 4,239,554 16.000% | 544,625 (+14.74%) | Filing History |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | BlackRock, Inc. BLK | 1,884,885 7.100% | 125,295 (+7.12%) | Filing History |
| 2022-04-11 1:47 pm Purchase | 2022-03-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | STATE STREET CORPORATION STT | 3,217,957 12.200% | 1,161,883 (+56.51%) | Filing History |
| 2022-02-14 9:41 pm Purchase | 2021-12-31 | 13G | VALLON PHARMACEUTICALS INC VLON | Arcturus Therapeutics Holdings Inc. ARCT | 28,125 12.380% | 28,125 (New Position) | Filing History |
| 2022-02-14 2:34 pm Sale | 2021-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | T. Rowe Price Associates, Inc. | 15,039 0.000% | -1,407,140 (-98.94%) | Filing History |
| 2022-02-14 1:07 pm Purchase | 2021-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Federated Hermes, Inc. FHI | 3,694,929 14.020% | 242,119 (+7.01%) | Filing History |
| 2022-02-14 06:04 am Purchase | 2021-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Amova Asset Management Americas Inc. | 1,357,472 5.150% | 1,357,472 (New Position) | Filing History |
| 2022-02-11 09:40 am Purchase | 2021-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | STATE STREET CORPORATION STT | 2,056,074 7.800% | 2,056,074 (New Position) | Filing History |
| 2022-02-09 2:03 pm Sale | 2021-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | ARK Investment Management LLC | 2,472,630 9.380% | -380,628 (-13.34%) | Filing History |